NYSE:MRK
Merck Stock News
$131.19
+0.310 (+0.237%)
At Close: May 17, 2024
Merck asks EU regulator to authorize its COVID-19 pill
05:35pm, Tuesday, 23'rd Nov 2021 ABC News
The European Medicines Agency says it has received a request from Merck to authorize its coronavirus antiviral, the first pill shown to treat COVID-19
EMA begins review of Merck''s COVID pill molnupiravir; opinion possible within weeks
05:16pm, Tuesday, 23'rd Nov 2021 Seeking AlphaDow Jones-Mover: Travelers Companies, salesforce.com, Verizon, Apple, Microsoft, Intel, Nike, Merck Co., Chevron und Wal-Mart
05:15pm, Tuesday, 23'rd Nov 2021 Borse Social NetworkMerck secures Health Canada approval for Keytruda and chemo combo for breast cancer
04:48pm, Tuesday, 23'rd Nov 2021 Seeking AlphaMerck Completes Acquisition of Acceleron Pharma
12:56pm, Tuesday, 23'rd Nov 2021 Smarter Analyst
Merck (MRK) revealed that it has completed the acquisition of Acceleron Pharma Inc. (XLRN) through its subsidiary Astros Merger Sub, Inc. The post Merck Completes Acquisition of Acceleron Pharma appeared first on Smarter Analyst .
Bionomics Files Registration Statement for Proposed Initial Public Offering in the United States
11:37am, Tuesday, 23'rd Nov 2021 PR Newswire Asia (English)
ADELAIDE, Australia , Nov. 23, 2021 /PRNewswire/ -- Bionomics Limited (ASX:BNO, OTCQB:BNOEF) ( Bionomics or Company ), a clinical-stage biopharmaceutical company, today announced the public filing of a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (the "SEC") in relation to a proposed public offering (the "Offering") of American Depositary Shares ( ADSs ), each of which will represent one or a number of the Company''s ordinary shares in the United States . Concurrent with the proposed public offering, Bionomics also intends to list the ADSs on the Nasdaq Stock Market ( Nasdaq ). All securities to be sold in the Offering will be offered by Bionomics. The number of securities to be sold and the price per ADS under any proposed Offering have not yet been determined. Bionomics has applied to list its ADSs on Nasdaq under the ticker symbol "BNOX". The ordinary shares are listed, and upon the completion of the Offering, will continue to trade on the Australian Securities Exchange ( ASX ) under the symbol "BNO".
Will Shareholder Love To Invest in This Stock? HIVE Blockchain Technologies Ltd. (NASDAQ:HIVE), Merck & Co., Inc. (NYSE:MRK)
10:45am, Tuesday, 23'rd Nov 2021 Stock Equity
HIVE Blockchain Technologies Ltd. (HIVE) with the stream of -5.12% also noticed, India Merck & Co., Inc. (MRK) encountered a rapid change of 1.01% in the last hour of Mondays The post Will Shareholder Love To Invest in This Stock? HIVE Blockchain Technologies Ltd. (NASDAQ:HIVE), Merck & Co., Inc. (NYSE:MRK) appeared first on Stocks Equity .
The pharmaceuticals market is expected to witness market growth at a rate of 6.95% in the forecast period of 2021 to 2028. Data Bridge Market Research report on pharmaceuticals market provides analysis and insights regarding the various factors expected to
Uterine Cancer Drugs Market Huge Growth in Future Scope 2021-2028 | Merck & Company, Inc., Actiza Pharmaceutical Private Limited, United Biotech Pvt Ltd
09:15am, Tuesday, 23'rd Nov 2021 OpenPR
top level players are analyzed in report based on current and future development status, and Uterine Cancer Drugs market estimations from 2021 to 2028 in terms of revenue and volume. This report provides strategic recommendations consulted
Albumin Antibody Market Aims to Expand at Double-Digit Growth Rate | Bethyl, Merck, Origene
08:23am, Tuesday, 23'rd Nov 2021 OpenPR
The Global Albumin Antibody Market Report provides up-to-date technical and financial information on the industry. The report delves into market characteristics, size and growth, segmentation, regional and country breakdowns, and the competitive landscape. This report examines the demand-supply scenario, pricing
Cytomegalovirus Vaccine Market Report- Top Manufacturers Mergers & Acquisitions | Merck, AlphaVax
07:06am, Tuesday, 23'rd Nov 2021 OpenPR
The Cytomegalovirus Vaccine Market research report provides accurate and comprehensive research studies on the vital aspects of the global market. Cytomegalovirus Vaccine Market focuses on the critical factors affecting the market growth of various segments and regions in the market.
Sinusitis Drugs Market May Set New Growth Story | Sanofi, Merck & Co. Inc., GlaxoSmithKline Plc., Intersect ENT Inc.
05:17am, Tuesday, 23'rd Nov 2021 OpenPR
Global Sinusitis Drugs Market: Snapshot The sinusitis drugs market has been expected to experience significant growth opportunities in the forthcoming years. This market growth is on the back of an increasing number of respiratory tract infections and growing cases of chronic
Covid pills promising but their utility yet uncertain
01:01am, Tuesday, 23'rd Nov 2021 The New Indian Express
Pfizers Paxlovid, Mercks Molnupiravir new drugs in Covid treatment
Blood Thinner Market Research Report: Probable Key Development To Be Observed Market States And Outlook Across By 2027|Bayer, Pfizer, Merck
10:52pm, Monday, 22'nd Nov 2021 OpenPR
Complete study of the global Blood Thinner market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the
Adult and Adolescent Vaccines Market Size, Analytical Overview, Growth Factors, Demand, Trends and Forecast to 2027|Merck, GlaxoSmithKline, Novartis
10:42pm, Monday, 22'nd Nov 2021 OpenPR
Complete study of the global Adult and Adolescent Vaccines market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding